z-logo
open-access-imgOpen Access
Non-Myeloablative Bone Marrow Transplant with Post-Transplant Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Transfusion Dependent Thalassemia: Results of an International Consortium (VGC2)
Author(s) -
Dilan A. Patel,
Rabi Hanna,
Leena Karnik,
James A. Connelly,
Carrie L. Kitko,
Adetola A. Kassim,
Josu de la Fuente
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.540
Subject(s) - medicine , thiotepa , fludarabine , cyclophosphamide , thalassemia , surgery , graft versus host disease , bone marrow , regimen , gastroenterology , transplantation , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom